Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYO1D antisense RNA 1 (MYO1D-AS1) appears to refer to a non-coding RNA transcript located antisense to the MYO1D gene. However, no curated scientific or clinical resources provide a defined function, classification, or disease relevance for MYO1D-AS1. Most available literature and databases address MYO1D, a protein-coding gene encoding myosin ID, rather than any antisense RNA labeled as "MYO1D-AS1." Thus, MYO1D-AS1 currently lacks established scientific information, is not recognized as a therapeutic target, and may reflect either a rarely annotated non-coding transcript or be a misnomer based on the naming convention for antisense lncRNAs. No aliases, molecular functions, disease involvement, biomarkers, or drugs are recognized for this entity in curated databases[3]. Most search hits and genetic databases focus on the protein-coding gene MYO1D (myosin ID), which is a class I unconventional myosin involved in cytoskeletal dynamics, vesicle trafficking, planar cell polarity, and epithelial integrity, with links to visceral heterotaxy and colitis[2][3]. No evidence was found for "MYO1D-AS1" as an established or characterized molecule in any clinical or experimental context. Therefore, this entry should be considered incorrect or unsupported as a therapeutic target based on currently available evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYO1D antisense RNA 1 (MYO1D-AS1).